PRESS RELEASE: BTZ-043 is tested on TB patients for the first time in Phase II study by PanACEA, funded by EDCTP BMBF: 'If BTZ043 proves to be safe and effective in the current study, this would be a major step in the development of a new drug' bit.ly/2E7Vudi